Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 20
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5774-5774
Open Access | Times Cited: 14
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Lisa Feldman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
Attila A. Seyhan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7974-7974
Open Access | Times Cited: 11
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 9
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Cranioencephalic functional lymphoid units in glioblastoma
Celia Dobersalske, Laurèl Rauschenbach, Yichao Hua, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2947-2956
Open Access | Times Cited: 8
Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics
Dingyi Yuan, Wenting Chen, Shasha Jin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1534-1546
Open Access | Times Cited: 6
In Silico Born Designed Anti-EGFR Aptamer Gol1 Has Anti-Proliferative Potential for Patient Glioblastoma Cells
Andrey V. Golovin, Fatima Dzarieva, Ksenia Rubetskaya, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1072-1072
Open Access
Gliomas Difusos do Adulto: Prevalência da Mutação IDH1 em um Hospital Universitário
V. Rizzo, Michelle Arrata Ramos, Eduardo Morais de Castro, et al.
Revista Brasileira de Cancerologia (2025) Vol. 70, Iss. 4
Open Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance
Xu Guo, Haozhe Piao, Rui Sui
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access
Trends in the immunotherapy for glioblastoma: A two-decade bibliometric analysis
Zhi Long, Zhenjie Yi, Wei Yan, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
Tanvir Ahmed, Kazi Tasnuva Alam
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
In Silico Validation of OncoOrigin: An Integrative AI Tool for Primary Cancer Site Prediction with Graphical User Interface to Facilitate Clinical Application
Petar Brlek, Luka Bulić, Nidhi Shah, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2568-2568
Open Access
Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors
Zhiguang Chen, Liang Sang, Zhai Qixi, et al.
Materials Today Bio (2025), pp. 101661-101661
Open Access
Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy
Mariko Takahashi, Darina Mukhamejanova, Himani Jasewicz, et al.
Cancer Science (2025)
Open Access
Dendritic Cell-Based Glioblastoma Vaccines: Advances and Challenges
Zuowen Zhang, Mingchang Li, Jie Huang
IntechOpen eBooks (2025)
Closed Access
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
Mengmeng Fu, Bing Xue, Xiangshui Miao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Khushi N. Panchal, Srinivas Mutalik, Jyothsna Manikkath
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 8
Open Access | Times Cited: 3
Immunotherapy for pediatric low-grade gliomas
Ian F. Pollack, James Felker, Stephen C. Frederico, et al.
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3263-3275
Closed Access | Times Cited: 2
Starting points for the development of new targeted therapies for glioblastoma multiforme
Agnieszka Rusak, Benita Wiatrak, Klaudia Krawczyńska, et al.
Translational Oncology (2024) Vol. 51, pp. 102187-102187
Closed Access | Times Cited: 2
Traitements du glioblastome – Trente années de progrès et rôle de l’immunothérapie
Jerzy Trojan
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 9, pp. 1317-1323
Closed Access
Page 1 - Next Page

Scroll to top